Demographics & Encounter
Patient ID240020 (PHI redacted)
Age / Gender68 / Male
Date of Service2026-04-10
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerMedicare VA
Reason1. Prostate pain
Diagnoses
C61
Malignant neoplasm of prostate
N40.0
Enlarged prostate
S32.592S
Other closed fracture of left pubis, sequela
N42.81
Prostatic pain
Medications
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day
Orgovyx(Relugolix)
valACYclovir HCl
Medication List reviewed and reconciled with the patient
Progress Note: [PROVIDER_NAME], MD 04/10/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/12/2026 04:39 PM EDT
1/4
4/13/26, 2:09 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026
Clinical Summary (HPI)
Prostate Cancer (localized): 68yM patient with gleason 4+3=7 prostate cancer s/p Barrigel/Fiducials (5/27/2025) and XRT (8/11/2025) presents today for FU on 6 month ADT Orgovyx (May'25 to Nov'25) - - - - - - - - - - - - - - The patient's previous work-up history is listed below: TREATMENT: Barrigel/Fiducials XRT (8/11/2025) Orgovyx(May'25-Nov'25) PSA: 7.6 (February 2024 - Verbal), 0.17 (Aug 2025) TESTO: 9 (Aug 2025) Decipher: 0.23; Low-risk (Feb'25) Prostate bx ( Feb 2025):LB 4+3=7 10% tissue, LM 3+3=6 20% tissue, LA 3+4=7 30% tissue, LLB 3+4=7 10% tissue, LLM 3+4=7 20% tissue, LLA 3+3=6 60% tissue, 1A 3+4=7 50% tissue, 1B 3+4=7 50% tissue, 1C 4+3=7 20% tissue pMRI (November 2024): 1. Left apex peripheral zone lesion, PI-RSDS v2.1 category 4. 2. No findings suspicious for tumoral extraprostatic extension or metastatic disease within the imaged pelvis. 3. Prostate volume of 42cc. PI-RADS 4. CT Abd/Pelvis (April 2024): Normal sized kidneys without obstruction. Bilateral simple renal cysts. No suspicious renal cortical mass or urolethial lesion. No evidence of metastatic disease. CMP: GLU 97, BUN 15.6, CREA 1.18, NA 131 L, CL 96 L. (Aug 2025) CBC: WBC 3.6 L, RBC 3.83 L, MONO% 13.1 H, LYMPH% 11.4 L, GRAN% 75.5 H (Aug 2025). BPH screening: with BPH. - - - - - - - - - - - - - - The patient's previous work-up history is listed below: Treatment: Tamsuolosin 0.4 mg.
Raw Note (de-identified preview)
4/13/26, 2:09 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026
[PATIENT_NAME]
68 Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: Medicare VA
(Palmetto)
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria
Structured Data: How did you hear about us? : Other; Patient's temperature : 0
04/10/2026 Progress Notes: [PROVIDER_NAME], MD
Reason for Appointment
1. Prostate pain
History of Present Illness
Prostate Cancer (localized):
68yM patient with gleason 4+3=7 prostate cancer s/p Barrigel/Fiducials (5/27/2025) and XRT (8/11/2025) presents today
for FU
on 6 month ADT Orgovyx (May'25 to Nov'25)
- - - - - - - - - - - - - -
The patient's previous work-up history is listed below:
TREATMENT: Barrigel/Fiducials XRT (8/11/2025)
Orgovyx(May'25-Nov'25)
PSA: 7.6 (February 2024 - Verbal), 0.17 (Aug 2025)
TESTO: 9 (Aug 2025)
Decipher: 0.23; Low-risk (Feb'25)
Prostate bx ( Feb 2025):LB 4+3=7 10% tissue, LM 3+3=6 20% tissue, LA 3+4=7 30% tissue, LLB 3+4=7 10% tissue, LLM
3+4=7 20% tissue, LLA 3+3=6 60% tissue, 1A 3+4=7 50% tissue, 1B 3+4=7 50% tissue, 1C 4+3=7 20% tissue
pMRI (November 2024): 1. Left apex peripheral zone lesion, PI-RSDS v2.1 category 4. 2. No findings suspicious for tumoral
extraprostatic extension or metastatic disease within the imaged pelvis. 3. Prostate volume of 42cc. PI-RADS 4.
CT Abd/Pelvis (April 2024): Normal sized kidneys without obstruction. Bilateral simple renal cysts. No suspicious renal
cortical mass or urolethial lesion. No evidence of metastatic disease.
CMP: GLU 97, BUN 15.6, CREA 1.18, NA 131 L, CL 96 L. (Aug 2025)
CBC: WBC 3.6 L, RBC 3.83 L, MONO% 13.1 H, LYMPH% 11.4 L, GRAN% 75.5 H (Aug 2025).
BPH screening:
with BPH.
- - - - - - - - - - - - - -
The patient's previous work-up history is listed below:
Treatment: Tamsuolosin 0.4 mg.
Current Medications
Taking
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day
Orgovyx(Relugolix) 120 MG Tablet 1 tab(s) orally once a day
Not-Taking
valACYclovir HCl 1 GM Tablet Oral
Medication List reviewed and reconciled with the patient
Progress Note: [PROVIDER_NAME], MD 04/10/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/12/2026 04:39 PM EDT
1/4
4/13/26, 2:09 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026
Past Medical History
Prostate Cancer.
Surgical History
Denies Past Surgical History
Family History
Father: deceased
Mother: deceased
Social History
Smoking: no
Recreational drug use: no.
Exercise: no.
Caffeine: yes.
Sexually active: no.
Occupation: no.
Tobacco Control (Standard)
Tobacco use: Nonsmoker
AUDIT-C (Standard)
Did you have a drink containing alcohol in the past year? No
Points 0
Interpretation Negative
Screening
Allergies
N.K.D.A.
Hospitalization/Major Diagnostic Procedure
Denies Past Hospitalizat